Updates

DOSE OF REALITY: UNPACKING THE REBATE RULE’S BIG PHARMA ORIGINS

Aug 3, 2020

Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A Read More

BIG PHARMA EARNINGS WATCH: ABBVIE & MERCK

Jul 31, 2020

Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations Read More

Big Pharma Earnings Watch: AstraZeneca & Eli Lilly

Jul 31, 2020

Brand Name Drug Companies See Soaring Profits After Hiking Prices Today Read More

BIG PHARMA EARNINGS WATCH: SANOFI

Jul 29, 2020

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant Read More

BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN

Jul 29, 2020

Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New Read More

THEY SAID IT! COVERAGE HIGHLIGHTS REVIVED REBATE RULE AN UNWORKABLE BIG PHARMA BAILOUT

Jul 28, 2020

Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers, Read More

CSRXP: WHITE HOUSE MUST STAND UP TO BIG PHARMA AND HOLD INDUSTRY ACCOUNTABLE FOR PRICE HIKES

Jul 27, 2020

Administration Should Withdraw Big Pharma-Backed Policies Like the Rebate Read More

REBATE RULE A BIG PHARMA BAILOUT PAID FOR ON THE BACKS OF AMERICAN SENIORS AND TAXPAYERS

Jul 24, 2020

Administration Should Abandon Previously Rejected Measure That Rewards Drug Read More

THEY SAID IT: GOP AND CONSERVATIVE LEADERS CONCERNED WITH NEGATIVE IMPACT OF REBATE RULE

Jul 22, 2020

HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS

Jul 22, 2020

Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Read More

DOSE OF REALITY: BIG PHARMA STICKS WITH PRICE-HIKING “BUSINESS AS USUAL” DURING PANDEMIC

Jul 20, 2020

AMERICAN VOTERS OVERWHELMINGLY SUPPORT MARKET-BASED SOLUTIONS TO HOLD DRUG Read More

DOSE OF REALITY: REBATE RULE WOULD HAND BIG PHARMA A MASSIVE BAILOUT AT TREMENDOUS COST TO SENIORS & TAXPAYERS

Jul 20, 2020

Policymakers Should Focus On Market-Based Solutions To Hold Drug Companies Read More